Investor alert: law offices of howard g. smith continues investigation of regeneron pharmaceuticals, inc. (regn) on behalf of investors

Bensalem, pa., dec. 03, 2024 (globe newswire) -- law offices of howard g. smith continues its investigation on behalf of regeneron pharmaceuticals, inc. (“regeneron” or the “company”) (nasdaq: regn) investors concerning the company's possible violations of federal securities laws.

REGN Ratings Summary

REGN Quant Ranking